Pre-clinical drug development is the stage of research that begins before clinical trials where the testing in humans is done can begin during which safety and efficacy of drug data is collected and then accesses the products safety profile.
Related Journals of Pre-clinical drug development
Drug Designing: Open Access, Advances in Pharmacoepidemiology & Drug Safety, Toxicology in Preclinical Drug Development, Drug Development Research, Journal of Pharmacology, Pharmaceutical Sciences.
The FDA generally required for the development of drug during pre-clinical studies include: 1) Development of a pharmacological profile of the drug 2) Determine the acute toxicity of the drug in at least two species of animals 3) Conduct short-term toxicity studies ranging from 2 weeks to 3 months, depending on the proposed duration of use of the substance in the proposed clinical studies.
